Clinical trial
High-flow Nasal Cannula Versus Noninvasive Positive Pressure Ventilation Therapy After Early Extubation for Patients With Chronic Obstructive Pulmonary Disease
NCT04156139 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High-flow Nasal Cannula Versus Noninvasive Positive Pressure Ventilation Therapy After Early Extubation for Patients With Chronic Obstructive Pulmonary Disease
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 18, 2019
- Completion date
- November 1, 2022
- Enrollment
- 502 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd, hypercapnic respiratory failure